Trials / Terminated
TerminatedNCT01755182
Systemic Therapy With or Without Upfront Transarterial Embolization for Inoperable Liver Metastasis of Neuroendocrine Tumors
Randomized Phase 3 Trial Evaluating the Efficacy of Locoregional Treatment With Transarterial Embolization (TAE) for Liver Metastases, in Combination With Pharmacotherapy, in Patients With Neuroendocrine Tumor and Inoperable Liver Metastasis.
- Status
- Terminated
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 1 (actual)
- Sponsor
- National Cancer Institute, Naples · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to verify if adding a locoregional treatment of liver metastasis (with trans-arterial embolization-TAE) to medical treatments of proven efficacy can prolong the progression free survival of patients affected by neuroendocrine tumors (NET) with inoperable liver metastases
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | approved pharmacologic therapy | |
| PROCEDURE | TAE | after randomization, and after 3 months |
Timeline
- Start date
- 2013-07-01
- Primary completion
- 2016-03-01
- Completion
- 2016-03-01
- First posted
- 2012-12-24
- Last updated
- 2016-05-06
Locations
12 sites across 1 country: Italy
Source: ClinicalTrials.gov record NCT01755182. Inclusion in this directory is not an endorsement.